Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter seriesPeter A. Nigrović, Gloria C. Higgins, Norman T. Ilowite et al.|Arthritis & Rheumatism|2010Cited by 465